drugset
drugset / Trial / NCT01938664

A Pilot Study of Candesartan as a Treatment for Cocaine Dependence

NCT01938664 ↗

Phase 2 Terminated 30 enrolled Baylor College of Medicine National Institute on Drug Abuse (NIDA) · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to see if a drug called Candesartan will help to reduce use of cocaine.

Timeline

Start
2013-01
Primary completion
2016-07
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Candesartan Unknown 8 mg Oral

Indications

cocaine dependence